PMC+1 Further, their original authorisation and indication were for glucose-controlnot for long-term, standalone obesity treatment
Fistula healing: BPC-157 has demonstrated the remarkable ability to heal complex gastrointestinal fistulas in animal models including gastrocutaneous, esophagocutaneous, duodenocutaneous, and colocutaneous fistulas (Seiwerth et al., 2021, Front Pharmacol )
It has been shown that DPP4-bound ADA has a 1000-fold greater activity than free ADA (123), which in turn may modulate the well-established antilipolytic effects of adenosine
doi: 10.1016/J.BIOPHA.2025.118364 252 LiKDengZLeiCDingXLiJWangC
Between high costs, insurance limitations, and potential side effects, these medications may not be the right fit for many
205 ACSL1 promotes peritoneal metastasis of ovarian cancer cells by reducing lipid peroxidation by lipid reprogramming